Irish add R&D (Research and Development) Finesse to medtech innovation drive
This article was originally published in Clinica
The Irish Medical Devices Association (IMDA) has given new impetus to its 2004-07 industry development plans, with the launch of a new R&D strategy that aims to bolster innovation in the medical devices and diagnostics sectors.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.